Identification of prognostic and diagnostic biomarkers of glucose intolerance in ApoE3Leiden mice

Physiological Genomics

Volumn 44, Issue 5, 2012, Pages 293-304

  Wopereis, Suzan ^a   Radonjic, Marijana ^a   Rubingh, Carina ^a   van Erk, Marjan ^a   Smilde, Age ^a   van Duyvenvoorde, Wim ^a   Cnubben, Nicole ^a   Kooistra, Teake ^a   van Ommen, Ben ^a   Kleemann, Robert ^a  

^a TNO   (Netherlands)

Author keywords

Diabetes mellitus Type 2; Diabetes mellitus Type 2 prone transgenic ApoE3Leiden mice; Plasma lipidomics; White blood cell transcriptomics

Indexed keywords

ACYL COA SYNTHETASE SHORT CHAIN FAMILY MEMBER 2; ADP RIBOSYLATION FACTOR GTAASE ACTIVATING PROTEIN 1; ATP BINDING CASSETTE SUBFAMILY B PROTEIN; BIOLOGICAL MARKER; CYTOCHROME C OXIDASE SUBUNIT VIB POLYPEPTIDE 2; CYTOCHROME P450 2B1; FATTY ACID; FIBROBLAST GROWTH FACTOR 16; LIPIDOME; SERYL AMINOACYL TRNA SYNTHETASE 2; TRANSCRIPTION ELONGATION FACTOR A LIKE 8 PROTEIN; TRANSCRIPTOME; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; LEUKOCYTE; LIPID BLOOD LEVEL; LIPID DIET; LIPIDOMICS; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; TRANSCRIPTOMICS;

ANIMALS; APOLIPOPROTEIN E3; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; GLUCOSE INTOLERANCE; LEUKOCYTES; LIPIDS; MALE; METABOLOME; MICE; MICE, TRANSGENIC; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; PROGNOSIS; TRANSCRIPTOME; VALIDATION STUDIES AS TOPIC;

ANIMALIA; MUS;

EID: 84857879280     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00072.2011     Document Type: Article

References (52)

1. CDC fact sheets [online; http://www.cdc.gov/diabetes/pubs/factsheet07.htm].2007.
2. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43: 1899-1907, 2002.
3. Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: Benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 48: 355-374, 2009.
4. Barker M, Rayens W. Partial least squares for discrimination. J Chemometrics17: 166-173, 2003.
5. Bergheanu SC, Reijmers T, Zwinderman AH, Bobeldijk I, Ramaker R, Liem AH, van der Greef J, Hankemeier T, Jukema JW. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins. Curr Med Res Opin 24: 2477-2487, 2008.
6. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, Van Ommen B, Smilde AK. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Analyt Chem78: 567-574, 2006.
7. Caesar R, Manieri M, Kelder T, Boekschoten M, Evelo C, Muller M, Kooistra T, Cinti S, Kleemann R, Drevon CA. A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS One 5: e11525, 2010.
8. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134: 933-944, 2008.
9. Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, Blaak EE. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia 49: 2392-2401, 2006.
10. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F. Evolving gene/ transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175, 2005.
11. De Groot PJ, Reiff C, Mayer C, Muller M. NuGO contributions to GenePattern. Genes Nutr 3: 143-146, 2008.
12. Draisma HH, Reijmers TH, Bobeldijk-Pastorova I, Meulman JJ, Estourgie-Van Burk GF, Bartels M, Ramaker R, van der Greef J, Boomsma DI, Hankemeier T. Similarities and differences in lipidomics profiles among healthy monozygotic twin pairs. OMICS 12: 17-31, 2008.
13. Frayn KN. Metabolic Regulation-A Human Perspective. Blackwell Science, 2003.
14. Fujino T, Kondo J, Ishikawa M, Morikawa K, Yamamoto TT. Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J Biol Chem 276: 11420-11426, 2001.
15. Gagliardi L, Wittert G. Management of obesity in patients with type 2 diabetes mellitus. Curr Diabetes Rev 3: 95-101, 2007.
16. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5: e10883,2010.
17. Haque FN, Gottesman II, Wong AH. Not really identical: epigenetic differences in monozygotic twins and implications for twin studies in psychiatry. Am J Med Genet C Semin Med Genet 151C: 136-141, 2009.
18. Haslinger B, Kleemann R, Toet KH, Kooistra T. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int 63: 2065-2074, 2003.
19. Hu C, Wei H, van den Hoek AM, Wang M, van der Heijden R, Spijksma G, Reijmers TH, Bouwman J, Wopereis S, Havekes LM, Verheij E, Hankemeier T, Xu G, van der Greef J. Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice. PLoS One 6: e19423, 2011.
20. Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan J, Esau C, Murphy C, Szalkowski D, Bergeron R, Doebber T, Zhang BB. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115: 1030-1038, 2005.
21. Kaestner KH, Ntambi JM, Kelly TJ Jr, Lane MD. Differentiationinduced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 264: 14755-14761, 1989.
22. Kleemann R, Princen HMG, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJG, Kooistra T, Havekes LM. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for anti-inflammatory effects of rosuvastatin. Circulation 108: 1368-1374,2003.
23. Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T. Timeresolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One 5: e8817, 2010.
24. Kleemann R, Verschuren L, van Erk MJ, Nikolsky Y, Cnubben NH, Verheij ER, Smilde AK, Hendriks HF, Zadelaar S, Smith GJ, Kaznacheev V, Nikolskaya T, Melnikov A, Hurt-Camejo E, van der GJ, van Ommen B, Kooistra T. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 8: R200, 2007.
25. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, Oresic M, Yki-Jarvinen H. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 58: 203-208, 2009.
26. Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, Niskanen LK, Salonen JT. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 19: 456-464, 2002.
27. Li J, Ding SF, Habib NA, Fermor BF, Wood CB, Gilmour RS. Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues. Int J Cancer 57: 348-352, 1994.
28. Lin Y, Sun Z. Current views on type 2 diabetes. J Endocrinol 204: 1-11,2010.
29. Luong A, Hannah VC, Brown MS, Goldstein JL. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem 275: 26458-26466,2000.
30. Miyazaki M, Jacobson MJ, Man WC, Cohen P, Asilmaz E, Friedman JM, Ntambi JM. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J Biol Chem 278: 33904-33911, 2003.
31. Ntambi JM, Buhrow SA, Kaestner KH, Christy RJ, Sibley E, Kelly TJ Jr, Lane MD. Differentiation-induced gene expression in 3T3-L1 preadipocytes Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 263: 17291-17300, 1988.
32. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99: 11482-11486, 2002.
33. Popeijus HE, Saris WH, Mensink RP. Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome. Int J Obes (Lond) 32: 1076-1082,2008.
34. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121: 1402-1411, 2011.
35. Sakakibara I, Fujino T, Ishii M, Tanaka T, Shimosawa T, Miura S, Zhang W, Tokutake Y, Yamamoto J, Awano M, Iwasaki S, Motoike T, Okamura M, Inagaki T, Kita K, Ezaki O, Naito M, Kuwaki T, Chohnan S, Yamamoto TT, Hammer RE, Kodama T, Yanagisawa M, Sakai J. Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2. Cell Metab 9: 191-202, 2009.
36. Smit S, van Breemen MJ, Hoefsloot HC, Smilde AK, Aerts JM, de Koster CG. Assessing the statistical validity of proteomics based biomarkers. Anal Chim Acta 592: 210-217, 2007.
37. Stefan N, Peter A, Cegan A, Staiger H, Machann J, Schick F, Claussen CD, Fritsche A, Haring HU, Schleicher E. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 51: 648-656, 2008.
38. Van Der Greef J, Martin S, Juhasz P, Adourian A, Plasterer T, Verheij ER, McBurney RN. The art and practice of systems biology in medicine: Mapping patterns of relationships. J Proteome Res 6: 1540-1559, 2007.
39. Van Vlijmen BJM, Van Den Maagdenberg AMJM, Gijbels MJJ, Van Der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 93: 1403-1410, 1994.
40. Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, van Erk M, de Vries-van der Weij J, Leng L, van Bockel JH, van Dijk KW, Fingerle-Rowson G, Bucala R, Kleemann R. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105: 99-107, 2009.
41. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43: 1353-1357, 1994.
42. Wade CM, Daly MJ. Genetic variation in laboratory mice. Nat Genet 37: 1175-1180, 2005.
43. Wang J, Yu L, Schmidt RE, Su C, Huang X, Gould K, Cao G. Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates. Biochem Biophys Res Commun 332: 735-742, 2005.
44. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78: 91-98, 2003.
45. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE. Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453, 2011.
46. Weiner FR, Smith PJ, Wertheimer S, Rubin CS. Regulation of gene expression by insulin and tumor necrosis factor alpha in 3T3-L1 cells. Modulation of the transcription of genes encoding acyl-CoA synthetase and stearoyl-CoA desaturase-1. J Biol Chem 266: 23525-23528, 1991.
47. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, Velzen EJJ, Duijnhoven JPM, Dorsten FA. Assessment of PLSDA cross validation. Metabolomics 4: 81-89, 2008.
48. Zadelaar S, Kleemann R, Verschuren L, de Vries-van der Weij J, van der Hoorn J, Princen HM, Kooistra T. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27: 1706-1721, 2007.
49. Zhang S, Yang Y, Shi Y. Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells. Biochem J 388: 135-142, 2005.
50. Zheng Y, Prouty SM, Harmon A, Sundberg JP, Stenn KS, Parimoo S. Scd3-a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics 71: 182-191, 2001.
51. Zhou YE, Egeland GM, Meltzer SJ, Kubow S. The association of desaturase 9 and plasma fatty acid composition with insulin resistanceassociated factors in female adolescents. Metabolism 58: 158-166, 2009.
52. Zhou YE, Kubow S, Dewailly E, Julien P, Egeland GM. Decreased activity of desaturase 5 in association with obesity and insulin resistance aggravates declining long-chain n-3 fatty acid status in Cree undergoing dietary transition. Br J Nutr 1-7, 2009.